Opioid Sparing Anaesthesia for Prevention of Postoperative Nausea and Vomiting in Laparoscopic Gynecological Surgery
PONV, Opioid Sparing Anaesthesia
About this trial
This is an interventional prevention trial for PONV focused on measuring Laparoscopic Gynecological Surgery, Dexmedetomidine, Ketamine, Lidocaine, PONV
Eligibility Criteria
Inclusion Criteria:
Patients scheduled for elective laparoscopic gynaecological surgery, who:
- had the American Society of Anesthesiologists (ASA) I or II physical status,
- were 21-60 years of age
Exclusion Criteria:
- A body mass index >35 kg/ m2
- Pregnant, breast feeding women
- Hepatic, renal or cardiac insufficiency
- Diabetes mellitus
- History of chronic pain
- Alcohol or drug abuse
- Psychiatric disease
- Allergy or contraindication to any of the study drugs
Sites / Locations
- Faculty of Medicine, Tanta University
Arms of the Study
Arm 1
Arm 2
Sham Comparator
Experimental
Normal saline (Control) group
Dexmedetomidine, ketamine and lidocaine (Study) group
A loading infusion of the 50 ml syringe (A) containing normal saline was started at rate of 0.2 ml/ kg/hr ten minutes before induction (as masking for mixture in group S). Then anesthesia was induced with 2 mg/kg ideal body weight (IBW) of propofol , patients were intubated with the aid of 0.5 mg/kg IBW atracurium and received 0.1ml/kg from syringe (C) containing fentanyl (1 mic/kg of IBW).
A loading infusion of syringe (B) containing the mixture was started at rate of 0.2 ml/kg/h ten minutes before induction. Then anesthesia was induced with 2 mg/kg IBW of propofol, patients were intubated with the aid of 0.5 mg/kg IBW atracurium and received 0.1ml/kg from syringe (D) containing normal saline (as masking for fentanyl in the control group).